The differentially classified samples included four non-BRCA1/2 tumours (FBC050798, FBC020636, FBC060411 and FBC070086) and one tumour from pathogenic BRCA2 mutation carrier (FBC013587) (Fig. 3). The gene discussed is BRCA1; the disease is neoplasm.